(Q28342791)

0 references

J T Aubin

0 references

D Guétard

0 references

V Favier

0 references

D Ingrand

0 references

J M Huraux

Human B-lymphotropic virus (human herpesvirus-6).

0 references

language of work or name

English

0 references

publication date

1989

1 reference

0 references

140

0 references

issue

0 references

page(s)

219-28

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Co-cultivation of human herpesvirus 6 and HIV1 from blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Fall in human herpesvirus 6 seropositivity with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Varicella-Zoster virus does not become more resistant to acyclovir during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Isolation of human lymphotropic herpesviruses from Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

DNA homology between a novel human herpesvirus (HHV-6) and human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Antibody to human herpesvirus 6 in HIV-1 positive and negative homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Molecular studies of HHV-6

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Strategies for antiviral therapy in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Inhibition of Herpesvirus Replication and Herpesvirus-Induced Deoxyribonucleic Acid Polymerase by Phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

In vitro inhibition of human herpesvirus-6 by phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

A novel lymphotropic herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Reversible inhibition of cytomegalovirus replication by phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2889%2980099-8

7 January 2021